42 unknown. 42 Phase 3, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 42 | Unknown 42 |
| Phase 2 | 9 | Unknown 9 |
Follow Prostate Cancer: new trials by email Literature Review of Prostate Cancer trials Research Report on Prostate Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage Enzalutamide 40 MG, Docetaxel injection - Prostate Cancer, Castrate Resistant Prostate Cancer | Phase 2 / Phase 3 | Unknown | Zhongnan Hospital | 120 | 2024-06-01 | 2024-02-28 |
| 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients 68Ga-PSMA-11, PET/CT or PET/MRI - Biochemical Recurrence of Malignant Neoplasm of Prostate, Prostate Cancer | Phase 3 | Unknown | Telix Pharmaceuticals (Innovations) Pty Limited | 110 | 2023-07-19 | 2024-07-03 |
| Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management rhPSMA-7.3 (18F) - Prostate Cancer | Phase 3 | Unknown | MidLantic Urology | 113 | 2023-04-27 | 2024-05-24 |
| Tranexamic Acid's Effects in Patients Undergoing Laparoscopic Radical Prostatectomy Tranexamic acid, Placebo - Prostate Cancer | Phase 3 | Unknown | Instituto do Cancer do Estado de São Paulo | 122 | 2023-04-01 | 2023-04-18 |
| Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7 Radiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine - Prostate Cancer, 18F- Fluorocholine | Phase 3 | Unknown | ITEL Telecomunicazioni Srl | 106 | 2022-12-19 | 2024-05-22 |
| Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients Al18F-PSMA-617, 68Ga-PSMA-617 - Prostate Cancer | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 100 | 2021-07-01 | 2023-05-03 |
| 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients 68Ga-PSMA-617, 68Ga-P16-093 - Prostate Cancer | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 50 | 2020-10-01 | 2022-08-09 |
| Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancer 68Ga-PSMA-11 PET, 18F-FCH PET - Prostate Cancer | Phase 3 | Unknown | Central Hospital, Nancy, France | 46 | 2019-02-01 | 2018-08-09 |
| Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency Everolimus, Placebo - Prostate Cancer | Phase 3 | Unknown | Tianjin Medical University Second Hospital | 120 | 2019-01-01 | 2018-07-09 |
| A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer SHR3680, Bicalutamide - Prostate Cancer, Hormone-Dependent Prostate Cancer | Phase 3 | Unknown | Jiangsu HengRui Medicine Co., Ltd. | 654 | 2018-05-30 | 2021-03-02 |
| Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients 68Ga-PSMA-11, 18F-Choline PET-CT - Prostate Cancer | Phase 2 / Phase 3 | Unknown | Central Hospital, Nancy, France | 33 | 2018-01-02 | 2017-11-17 |
| Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy Sildenafil 25 MG Oral Tablet, Pentoxifylline, Placebo - Erectile Dysfunction, Prostate Cancer | Phase 3 | Unknown | Brooke Army Medical Center | 180 | 2017-02-13 | 2018-01-23 |
| Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium Minocycline, Placebo - Prostate Cancer, Carcinoma of the Rectum | Phase 3 | Unknown | RenJi Hospital | 750 | 2016-11-01 | 2020-01-28 |
| Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases SBRT, Standard of Care - Prostate Cancer, Breast Cancer | Phase 2 / Phase 3 | Unknown | Royal Marsden NHS Foundation Trust | 245 | 2016-11-01 | 2019-08-21 |
| IG-VMAT for Localized Prostate Cancer hypofraction, convention - Prostate Cancer | Phase 3 | Unknown | Beijing Hospital | 60 | 2016-06-01 | 2016-11-18 |
| Prospective RCT on Post Prostatectomy Urine Leak Duloxetine, Pelvic Floor Muscle Training - Prostate Cancer, Urinary Incontinence | Phase 3 | Unknown | Institut Mutualiste Montsouris | 240 | 2015-05-01 | 2016-09-13 |
| Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate Cancer Focal Therapy Using High Intensity Focused Ultrasound - Prostate Cancer | Phase 2 / Phase 3 | Unknown | University of Zurich | 100 | 2014-05-01 | 2016-10-27 |
| The Metformin Active Surveillance Trial (MAST) Study Metformin, Placebo - Prostate Cancer | Phase 3 | Unknown | University Health Network, Toronto | 408 | 2013-10-01 | 2024-01-24 |
| Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer CF-CRT combined with BT or SBRT boost., CF-CRT alone, Hormonal treatment (neoadjuvant androgen deprivation) - Prostate Cancer | Phase 3 | Unknown | Maria Sklodowska-Curie National Research Institute of Oncology | 350 | 2013-06-01 | 2013-04-25 |
| Focal Therapy Using HIFU for Localised Prostate Cancer High Intensity Focused Ultrasound - Prostate Cancer | Phase 2 / Phase 3 | Unknown | Jewish General Hospital | 25 | 2013-03-17 | 2017-04-19 |
Showing 20 of 42. Sign in to see all of them.
Prostatic Neoplasms (42) · Neoplasms (4) · Breast Neoplasms (2) · Osteoporosis (2) · Pain (2) · Rectal Neoplasms (2) · Anemia (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Ovarian Epithelial (1) · Carcinoma, Renal Cell (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Disease (1) · Emergence Delirium (1) · Endometrial Neoplasms (1)
Genital Diseases (42) · Genital Diseases, Male (42) · Genital Neoplasms, Male (42) · Male Urogenital Diseases (42) · Neoplasms by Site (42) · Prostatic Diseases (42) · Urogenital Diseases (42) · Urogenital Neoplasms (42) · Neoplasms (38) · Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (5) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Neurologic Manifestations (3) · Urologic Diseases (3)
Docetaxel (5) · bicalutamide (3) · Androgen Antagonists (2) · Flutamide (2) · Gonadotropin-Releasing Hormone (2) · Goserelin (2) · Leuprolide (2) · Radiotherapy (2) · Triptorelin Pamoate (2) · 18F-JK-PSMA-7 (1) · Absorptiometry, Photon (1) · Blood Specimen Collection (1) · Buserelin (1) · Calcitriol (1) · Chemotherapy, Adjuvant (1)
Central Hospital, Nancy, France (2) · Peking Union Medical College Hospital (2) · Royal Marsden NHS Foundation Trust (2) · Scandinavian Prostate Cancer Group (2) · VA Puget Sound Health Care System (2) · A.O.U. San Giovanni Battista di Torino, Italy (1) · Amphia Hospital (1) · Beijing Hospital (1) · Brooke Army Medical Center (1) · Canadian Urology Research Consortium (1) · EDAP TMS S.A. (1) · ITEL Telecomunicazioni Srl (1) · Institut Mutualiste Montsouris (1) · Instituto do Cancer do Estado de São Paulo (1) · Jewish General Hospital (1)
China (9) · United States (9) · Canada (8) · United Kingdom (5) · France (3) · Australia (2) · Denmark (2) · Italy (2) · Norway (2) · Poland (2) · Sweden (2) · Bulgaria (1) · Czechia (1) · Finland (1) · Iceland (1)
Kent E Wallner, MD (2) · Alan Pollack, MD, PhD (1) · Anthony Joshua, MD (1) · Bo Abrahamsen, MD, PhD, Professor (1) · Carey Robertson, MD (1) · Claus Dahl, MD (1) · Daniel Eberli, PD Dr. PhD (1) · Deborah A. Kuban, MD (1) · Dingwei Ye, M.D. (1) · Franck Bladou, MD (1) · Gaofeng Li, director (1) · Gillian M. Duchesne, MD, FRCR (1) · Goran Ahlgren, MD, PhD (1) · Isabella Chiappino, MD (1) · John Gerard Armstrong, MD, MB, MRCPI (1)
PMID 11895205, PMID 14630265, PMID 15840561, PMID 20797824, PMID 20800404, PMID 21350618, PMID 21844889, PMID 23465742, PMID 23559588, PMID 23797218, PMID 24072344, PMID 24207135, PMID 24920079, PMID 25203127, PMID 25411132, PMID 25447835, PMID 26707868, PMID 27155740, PMID 27363387, PMID 28433432, PMID 28518227, PMID 28581398, PMID 28760403, PMID 29388336, PMID 30017404, PMID 30027419, PMID 30174470, PMID 30245169, PMID 30389823, PMID 30448957, PMID 30507748, PMID 31324713, PMID 31516367, PMID 31708295, PMID 31836681, PMID 31836682, PMID 34557930, PMID 34895925, PMID 35569466, PMID 36075260, PMID 36727866, PMID 36884035, PMID 37973477, PMID 39419035, PMID 39690158, PMID 40367400, PMID 41880608, PMID 42380973
2005 (1), 2017 (1)